BTK is involved in the pathogenesis of CLL since constitutive activation of the kinase is linked to constitutive activation of the BCR signaling pathway and consequently increased survival and proliferation of malignant cells. Here, BTK is linked to B-cell chronic lymphocytic leukemia.